Aytu Biopharma (AYTU) Other Operating Expenses (2010 - 2026)

Aytu Biopharma (AYTU) has 17 years of Other Operating Expenses data on file, last reported at $6.7 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 518.3% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $36.6 million, a 231.04% increase from a year earlier, with the FY2025 full-year figure at $32.9 million, up 409.18% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $6.7 million, up from $526000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for AYTU reached as high as $48.7 million in Q1 2022 and fell as low as -$4.9 million in Q2 2022.
• Historically, Other Operating Expenses has averaged $8.8 million across 5 years, with a median of $6.3 million in 2024.
• Across the five-year window, Other Operating Expenses slumped 627.6% in 2022 and soared 1376.31% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $14.4 million in 2022, then plunged by 57.49% to $6.1 million in 2023, then tumbled by 76.48% to $1.4 million in 2024, then slumped by 63.55% to $526000.0 in 2025, then surged by 1171.86% to $6.7 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $6.7 million in Q1 2026, $526000.0 in Q4 2025, and $444000.0 in Q3 2025.